Core Insights - The company, Wuxi Xiangsheng Medical Technology Co., Ltd., is leveraging its deep technical expertise in ultrasound and innovation capabilities to navigate challenges, showing a stable upward trend in operational performance [1] - Xiangsheng Medical is actively embracing the "AI + Ultrasound" technology trend and is advancing its animal ultrasound business, aiming to deepen collaboration with global partners [1] Group 1: AI Ultrasound Innovations - As a leader in the AI ultrasound field, the company is establishing a comprehensive intelligent technology ecosystem driven by "ultrasound artificial intelligence + specialized models" [1] - The company has developed an intelligent standard framework covering "equipment research and development - image acquisition - diagnostic decision-making," creating a service network that integrates "precise screening - intelligent diagnosis - personalized rehabilitation" [1] Group 2: Veterinary Ultrasound Products - In 2025, the company successfully launched the SonoVet series of veterinary ultrasound products, which cater to various applications such as large animal reproduction and small animal abdominal and cardiovascular examinations [1] - These products are designed to meet diverse environmental needs in settings like farms, pet hospitals, mobile quarantine, and wildlife care, addressing pain points such as low image resolution and reliance on operator experience in traditional veterinary ultrasound [1] Group 3: Robotics and AI Integration - In addition to AI technology integration, the company has made significant breakthroughs in the robotics field, developing core technologies such as "visual recognition and analysis" and "precise control of robotic movement" [2] - The company has launched the "AI + Robot Scanning" series of solutions, with its flagship product, the "Breast Artificial Intelligence Ultrasound Robot," being the first to obtain a medical device testing report [2]